Curaleaf Holdings, Inc.
CURA.TOTSXHealthcare● Active
$15.60
$-0.61(-3.76%)
Market Cap$3.6B
P/E Ratio—
52W High$20.925
52W Low$1.1
Curaleaf Holdings, Inc. (CURA.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CURA.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.25B) | ($0.22B) | ($0.24B) | ($0.38B) | ($0.11B) |
| Depreciation & Amort. | $0.22B | $0.25B | $0.21B | $0.18B | $0.13B |
| Stock-Based Comp. | $0.00B | $0.03B | $0.02B | $0.03B | $0.04B |
| Change in Working Capital | $0.12B | $0.10B | $0.03B | $0.11B | ($0.09B) |
| Net Cash from Operations | $0.14B | $0.16B | $0.08B | $0.05B | ($0.03B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.06B) | ($0.10B) | ($0.07B) | ($0.14B) | ($0.17B) |
| Purchases of Investments | ($0.00B) | ($0.00B) | $0.00B | ($0.01B) | ($0.03B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.01B | $0.03B |
| Net Cash from Investing | ($0.07B) | ($0.09B) | ($0.08B) | ($0.23B) | ($0.16B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.03B) | ($0.04B) | ($0.05B) | $0.06B | $0.18B |
| Net Cash from Financing | ($0.07B) | ($0.05B) | ($0.07B) | $0.05B | $0.42B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.08B | $0.06B | $0.01B | ($0.09B) | ($0.21B) |
| FCF Margin %(computed) | 5.87% | 4.80% | 0.37% | -6.88% | -17.02% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Curaleaf Holdings, Inc. data
About Curaleaf Holdings, Inc. (CURA.TO) Cash Flow Statement
Curaleaf Holdings, Inc. generated operating cash flow of $0.14B and free cash flow of $0.08B for 2025 — a FCF margin of 5.87%. Capital expenditure was ($0.06B).
Frequently asked questions
CURA.TO · 4 questionsCuraleaf Holdings, Inc. generated free cash flow of $0.08B for 2025, up 17.7% year-over-year.
CURA.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10